Showing 1 - 2 results of 2 for search 'Ryuji Yoshida', query time: 0.01s
Refine Results
-
1
-
2
Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: results from a 28-week open-label treatment period of a randomised trial by Koichi Hirata, Fumihiko Sakai, Miki Hasebe, Takao Takeshima, Yotaro Numachi, Ryuji Yoshida, Reija Koukakis, Daishi Yui, Gabriel Paiva da Silva Lima, Sunfa Cheng
Published 2023-08-01Get full text
Article